24.06.2024 | Tracker
Respiratory Tracker: LAURA trial received close examination from HCPs
Between 21 May and 20 June 2024, CREATION Pinpoint® tracked the conversations of UK online healthcare professionals (eHCPs) discussing respiratory diseases on X (Twitter). We analysed 2,000 posts discussing respiratory diseases by 876 eHCPs.
During the 2024 American Society of Clinical Oncology (ASCO) conference, held from May 31 to June 3, HCPs in the UK were very active online discussing respiratory diseases. When using the hashtag #ASCO24, more than half of these HCPs referenced non-small cell lung cancer (NSCLC).
A key topic included AstraZeneca’s LAURA trial, discussed by seven UK HCPs in 15 posts. Some suggested data from the LAURA trial would potentially pave the way for a new standard of care for stage 3 EGFR-mutant NSCLC as it received a rousing ovation from the audience at ASCO. However some others, like oncologist Sanjay Popat, questioned whether the trial results were positive.
LAURA Trial receives a well deserved huge applause by the audience. Huge benefit in PFS (39 vs 5.6 mo, HR < 0.2. OS still immature and 81% crossover. STAGE III EGFR+ NSCLC INCURABLE? BRAIN RMN BUT NO PET-CT required at baseline. #ASCO24 @LeciaSequist pic.twitter.com/mJlGuqFKQ5
— Noemi Reguart (@NReguart) June 2, 2024
HCPs also shared news about multiple trials and studies related to COPD, focusing particularly on medications and patient care. Emphasis was placed on the importance of recognising and managing COPD exacerbations and the use of rescue packs. In the same vein, HCPs celebrated Pulmonary Rehabilitation Week and the value of rehabilitation in COPD, bronchiectasis, pulmonary fibrosis and severe asthma management.
A new initiative was also shared by four HCPs, the development of the myCOPD app to help patients with COPD manage their condition. The app, now recommended by NICE, will be enhanced with AI-enabled alerts.
For people with COPD who cannot have or decline proper face-to-face pulmonary rehabilitation, myCOPD can be used in the NHS while more evidence is generated https://t.co/CYJDuBv21f @NICEComms
— Dr Nick Hopkinson (@COPDdoc) April 30, 2024
In June, UK HCPs shared their concerns about air pollution online. During awareness days like Clean Air Day, HCPs discussed the importance of addressing this issue. The detrimental impact of air pollution on children’s respiratory health was also highlighted. A manifesto and position statements were shared by HCPs as they called for ambitious new legislation to combat toxic air pollution and promote smoke-free generations. Clare Nash, a nurse in Bridgnorth, shared how ‘the disease burden attributable to air pollution reflects regional patterns of socioeconomic deprivation.”
Health inequalities are being made worse by air pollution:
Improving air quality in the WMids could avoid 2,000 new asthma cases, 770 new cases of heart disease, 170 new lung cancers and 650 strokes annually.— Clare Nash 💙💚 RN 🌍 #Followbackclimate (@ClareNash20) June 11, 2024
Each month, we track the eHCP conversation relating to respiratory disease. You can read other editions in the Respiratory Tracker archive .
You can also keep updated with other pharmaceutical tracking updates, including how eHCPs engage with Top 50 pharma and the product approvals that are catching their attention. To receive updates straight to your inbox you can sign up for our monthly eJournal with our latest HCP insights.
Methodology
- CREATION Pinpoint® was used to analyse 2,000 mentions on X from 876 HCPs in the UK discussing respiratory disease and related terms, between 21 May 2024 and 20 June 2024.